Vascular Stents Market Research Report Information by Type [Coronary Stents, Peripheral Stents (Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents, Iliac Artery Stents and others) and Evar Stent Grafts (Abdominal Aortic Aneurysm Stents and Thoracic Aortic Aneurysm Stents)], Material [Metallic Stents (Platinum Chromium, Cobalt-Chromium, Nickel-Titanium and Stainless Steel), Ceramics Stents and Polymers Stents], End User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers) and Region - Forecast till 2032

Global Vascular Stents Market Overview

Vascular Stents Market Size was valued at USD 6.62 Billion in 2023. The Global Vascular Stents industry is projected to grow from USD 7.10 Billion in 2024 to USD 14.37 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.59% during the forecast period (2024 - 2032).

Vascular Stents are medical equipment that clears any blockages in arteries and valves. The equipment is also used to clean up blockages in cases of emergencies. The Vascular Stents also act as a support system for the stenotic support system.

ReFlow Medical’s vascular stent showed encouraging early results in June 2023. The six-month data indicated that 86% of patients with infrapopliteal arterial disease had patency rates.

Cordis announced its plans to take over MedAlliance, a Swiss firm recognized for its creativity concerning drug-eluting balloons. This is because Cordis has a strategic formula of becoming the global leader and potentially providing treatment to about two million patients by 2027 through the use of MedAlliance’s SELUTION SLR (Sustained Limus Release) drug-eluting balloon.

BIOTRONIK's Pulsar-18 T3 peripheral self-expanding stent system was given FDA approval on July 2022, becoming the first and only such kind of low-profile stent system within 4-french. It has been designed using the tri-axial approach, which ensures accurate and stable placement, minimizing complications and the need for closure devices.

On May 13th, 2022, health technology giant Medtronic Plc disclosed that they had received FDA approval on Onyx Frontier™ drug-eluting stent (DES). The newest member of Resolute DES family, Onyx Frontier DES, taps into a class-leading stent platform, having improved delivery system meant to enhance deliverability and raise acute performance even in most challenging cases.

Cordis received US FDA clearance for Smart Radianz Vascular Stent System in March 2022; this product is expected to expand Cordis' peripheral market share.

October 6th 2020, Boston Scientific Corporation gave a positive Eluvia stent trial during a late-breaking session in Las Vegas during Vascular InterVentional Advances (VIVA) conference. These results highlight Eluvia superiority over self-expanding bare metal stents (BMS) in the treatment of patients with peripheral artery disease (PAD) involving focal SFA lesions up to 210 mm in length.

December 17th, 2020: Bridge® Vertebral Drug-Eluting Stent developed by MicroPort NeuroTech Co., Ltd., a subsidiary of MicroPort Scientific Corporation, was issued with a registration certificate from the National Medical Products Administration (NMPA) of China for the treatment of symptomatic vertebral artery stenosis.

The primary factor driving the Vascular Stents Market is the rapid growth of the geriatric population. A considerable number of Peripheral Artery Disease (PAD) cases have been. The patients have been dealing with constant ailments related to the heart and lungs. This is due to the adoption of the luxurious lifestyle that comes with the consumption of alcohol, smoke, and others. An increasing number of angioplasty procedures, vascular diseases, and other invasive procedures are majorly responsible for driving the Market. However, the consistent use of physical and chemical optimization over all other methods of Vascular Stents acts as a major restraint for the Market. Along with that, there have been cases of short-coming factors like first-generation Vascular Stents that have caused inconvenience in the production and marketing of the Market. Despite this, substantial growth is predicted for the market in its forecast period.

Covid 19 analysis

In the 21st century, the Covid 19 pandemic has acted as a major factor that has redefined this market landscape at the global level. Due to stringent regulations and norms relating to social distancing, people suffering from vascular complexities have not been able to get suitable treatment for vascular health conditions. It has adversely affected the overall demand for vascular stents in the vast market. However, the pandemic has also created diverse opportunities for business entities. For instance, businesses have been integrating new types of digital technologies in the business processes to deliver improved quality of care and treatment. 

Vascular Stents Major market Trends

• 
  

  Vascular Stents Industry Drivers

  
  

The rise in the incidence of vascular conditions among people all across the globe has increased the demand in the vascular stents market. People have been opting for minimally invasive medical procedures instead of undergoing serious and complex surgeries. Another factor that acts as a major market driver is the rapid innovation in stenting technologies. These elements could contribute to the rise in the global market value during the forecasted period.

• 
  

  Vascular Stents Industry Challenges

  
  

A number of challenges exist in the global vascular stents market landscape and increase the complexity for business players that function in it. One of the major challenges revolves around the regulatory requirements. Businesses need to adhere to the latest laws and legislation while working on their innovative vascular stenting solutions. Another challenge that exists in the global market setting is the intense competition. Based on the forecast, most market players have been working on their strategic approaches to capture a considerable portion of this global industry share.

• 
  

  Opportunities in the Global Peripheral Stents Industry

  
  

Several opportunities exist in the global market, such as adopting innovative technologies to strengthen the effectiveness and safety of the treatment procedure. The industry's attractiveness is considered high as people have been inclined towards minimally invasive vascular surgeries. Several industry players have been integrating new digital technologies to capitalize on favorable market conditions. The existence of diverse opportunities during the forecasted period could influence its industry value.

• 
  

  Peripheral Stents Industry Restraints

  
  

A major restraint in the global market relates to the high instances of product failure. Similarly, there are also many instances of product recalls which affect the growth of the market. Based on the detailed evaluation of the vascular stents industry, these elements could adversely affect the performance of the market in the future. 

• 
  

  Cumulative Evaluation of the Peripheral Stents Industry

  
  

The comprehensive vascular stents market outlook report has captured a diverse range of variables in the global market setting. Some of the chief factors that have been identified include the rise in vascular health complexities in individuals at the global level and the integration of new technologies in the vascular stenting landscape. These are the major components that are likely to impact the performance of the market during the forecasted period. 

Vascular Stents Market Segment Insights

Vascular Stents Type Insights

The global vascular stents market can be categorized into coronary stents, peripheral stents, and evar stent grafts based on type. During the forecasted period, the coronary stents segment will likely dominate the global market landscape and influence the overall size of angioplasty. The main factors that could lead to its slid performance include the high incidence of coronary artery disease and rapid advancement in coronary stents.

Vascular Stents Material Insigts

Based on the material, the global market can be fragmented into metallic stents, cobalt-chromium, platinum chromium, nickel-titanium, stainless steel, polymers stents, and ceramics stents. The polymers stents segment has been dominating the global market due to the rise in the application of bioabsorbable sterns. It is likely to dominate the global market setting during the forecasted period as well. 

Vascular Stents End-User Insights

Based on end-users, the global vascular stents market can be categorized into hospitals, cardiac centers, and ambulatory surgical centers. The hospital is the major end-user segment that has been shaping the performance of the global industry landscape. The main reasons for the exceptional performance of the specific end-user segment include the high availability of angioplasty procedures and the increased expertise in healthcare settings. The hospital segment is likely to dominate the global market setting and contribute to its performance during the forecasted period.   

Vascular Stents Regional Insights

The global vascular stents market can be divided into regions, including the Americas, Europe, Asia Pacific, the Middle East, and Africa. A diverse range of factors influences the performance of these regional market segments, such as the prevalence of vascular diseases and the availability of a robust technological infrastructure. During the forecasted period, the Americas could capture most of the vascular stents industry share due to the high prevalence of health-related disorders and the rapid adoption of digital technologies. The increasing preference for non-invasive or minimally invasive procedures could further boost the industry growth. A diverse range of factors could come into play and influence the degree of market growth in respective regions. However, a major driving factor in most of the geographical segments includes the rising incidence of vascular health conditions in people.   

Competitive intensity in the Vascular Stents Industry

The competitive intensity in the global market is very high due to numerous business players. Some of the top companies that have been intensifying the competition in the global business landscape are as follows: 

• Abbott Laboratories


• Boston Scientific Corporation


• Medtronic Plc.


• Terumo Corporation


• Microport Scientific Corporation


• Vascular Concepts


• C. R. Bard


• Merril Life Sciences


• Biotronic SE & Co. KG


• Cordis Corporation


• Cook Medical

To sustainably function in the competitive global market, business firms have been integrating new digital technologies to facilitate vascular stents innovations. Based on the critical market analysis, the strategic approach of the businesses could influence the market performance during the forecasted period.  

Recent Market Developments

The Market has been engaged with some of the significant key players of the market like Cordis Corporation, Medtronic, Boston Scientific Corporation, Life science Scientific, Cook Medical, and W.L.Gore and Biosensors International Group. These companies have been collaborating and launching equipment that has helped with the recent market developments.

Vascular Stents Market Report Overview

The vascular stents market outlook report has given a critical insight into the market and the varying factors that exist in it. The increase in the prevalence of vascular diseases acts as the catalyst and influences the market performance. According to the specific vascular stents industry forecast, the high disease prevalence could contribute to the market's growth. One of the top vascular stents market trends that have been captured in the report involves the rapid adoption of technology. A major bottleneck that has been adversely affecting the vascular stents industry performance is the rise in product failure.  

Vascular Stents Market Segmentation

Vascular Stents Type Outook

• Coronary Stents


• Peripheral Stents


• EvarStent Grafts

Vascular Stents Material Outlook

• Metallic Stents


• Cobalt-Chromium


• Platinum Chromium


• Nickel Titanium


• Stainless Steel


• Polymers Stents


• Ceramics Stents

Vascular Stents End-User Outlook

• Hospitals


• Cardiac Centers


• Ambulatory Surgical Centers